RONALD DRESCHER: Open Payments
NPI 1942306956 · CLINTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 77 payments from 23 companies in 2025. Trend: 2023 $1,186 · 2024 $1,319 · 2025 $1,209
Food & beverage: $1,209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $239 |
| Lilly USA, LLC | 10 | $124 |
| Axsome Therapeutics, Inc. | 6 | $118 |
| PFIZER INC. | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Abbott Laboratories | 3 | $52 |
| HARMONY BIOSCIENCES LLC | 3 | $47 |
Products named: VRAYLAR, MOUNJARO, CAPLYTA, JARDIANCE, NURTEC ODT, QULIPTA, Auvelity, Sunosi.
Industry payments across UT — which companies pay providers there.
